181 related articles for article (PubMed ID: 2179855)
21. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
Gilsdorf JR; McDonnell WM
Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
[TBL] [Abstract][Full Text] [Related]
22. New vaccines against Haemophilus influenzae type b.
Shapiro ED
Pediatr Clin North Am; 1990 Jun; 37(3):567-83. PubMed ID: 2190140
[TBL] [Abstract][Full Text] [Related]
23. Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use.
Black SB; Shinefield HR; Fireman B; Hiatt R
J Infect Dis; 1992 Jun; 165 Suppl 1():S139-43. PubMed ID: 1588149
[TBL] [Abstract][Full Text] [Related]
24. [When should vaccination against Haemophilus influenzae type b take place?].
Stickl HA
Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
[No Abstract] [Full Text] [Related]
25. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
Weinberg GA; Granoff DM
Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
[No Abstract] [Full Text] [Related]
26. Haemophilus influenzae type B conjugate vaccines.
Force RW; Lugo RA; Nahata MC
Ann Pharmacother; 1992 Nov; 26(11):1429-40. PubMed ID: 1477450
[TBL] [Abstract][Full Text] [Related]
27. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
28. [Haemophilus influenzae type b infections in children].
Neijens HJ; de Groot R; Dzoljic-Danilovic G
Ned Tijdschr Geneeskd; 1991 Jan; 135(1):13-6. PubMed ID: 1990297
[No Abstract] [Full Text] [Related]
29. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group.
Wenger JD; Pierce R; Deaver KA; Plikaytis BD; Facklam RR; Broome CV
Lancet; 1991 Aug; 338(8764):395-8. PubMed ID: 1678080
[TBL] [Abstract][Full Text] [Related]
30. [Conjugated vaccines against Haemophilus influenzae type b].
Rümke HC; Poolman JT
Ned Tijdschr Geneeskd; 1991 Jan; 135(1):4-7. PubMed ID: 2012643
[No Abstract] [Full Text] [Related]
31. Comparative immune responses to Haemophilus influenzae type b polysaccharide and a polysaccharide-protein conjugate vaccine.
Kim KS; Wong VK; Adler R; Steinberg EA
Pediatrics; 1990 Apr; 85(4 Pt 2):648-50. PubMed ID: 2107516
[No Abstract] [Full Text] [Related]
32. Molecular epidemiology of Haemophilus influenzae type b.
van Alphen L; Bijlmer HA
Pediatrics; 1990 Apr; 85(4 Pt 2):636-42. PubMed ID: 2179853
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age.
Loughlin AM; Marchant CD; Lett S; Shapiro ED
Pediatr Infect Dis J; 1992 May; 11(5):374-9. PubMed ID: 1630857
[TBL] [Abstract][Full Text] [Related]
34. Antibody responses to four Haemophilus influenzae type b conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Rönnberg PR; Kela E; Karanko V; Saarinen L
Am J Dis Child; 1991 Feb; 145(2):223-7. PubMed ID: 1994693
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
36. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
Glezen WP; Englund JA; Siber GR; Six HR; Turner C; Shriver D; Hinkley CM; Falcao O
J Infect Dis; 1992 Jun; 165 Suppl 1():S134-6. PubMed ID: 1588147
[TBL] [Abstract][Full Text] [Related]
37. Frequency of detection of Hemophilus influenzae type b capsular polysaccharide in infants and children with pneumonia.
Wald ER; Levine MM
Pediatrics; 1976 Feb; 57(2):266-8. PubMed ID: 1082573
[TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide and its tetanus toxoid conjugate in patients with recurrent infections or humoral immunodeficiency.
Barra A; Bremard-Oury C; Bajart A; Griscelli C; Fritzell B; Preud'homme JL
Int J Clin Lab Res; 1992; 21(3):231-4. PubMed ID: 1591374
[TBL] [Abstract][Full Text] [Related]
39. Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type B vaccine.
Rowe JE; Messinger IK; Schwendeman CA; Popejoy LA
Mil Med; 1990 Oct; 155(10):483-6. PubMed ID: 2122290
[TBL] [Abstract][Full Text] [Related]
40. [Haemophilus diseases nearly eradicated in Finland].
Eskola J; Rönnberg PR; Mäkelä PH
Lakartidningen; 1992 May; 89(21):1893-4. PubMed ID: 1598056
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
